Metatron Health

Botanical species · safety record

Mimosa pudica

The EFSA Compendium of Botanicals holds 7 constituent measurements and 2 adverse-effect records for Mimosa pudica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Mimosa pudica L.

7Constituent measurements
2Safety records
6Cited sources
7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Mimosa pudica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Leaf
  • Root
  • Whole plant

What the records describe

Constituents measured

  • Tannins2
  • Alkaloids1
  • Gallic acid1
  • Mimosine1
  • P-coumaric acid1
  • Saponins1

Plant parts

  • Leaves3
  • Live plants3
  • Roots and other underground parts1
  • Seed1
  • Unspecified1

Preparations

  • Solvent extraction9

Effect types

  • Hepatotoxicity1
  • Reproductive1

Target tissues

  • Liver1
  • Urogenital1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extraction—Phytochemical screeningResolve DOI
SaponinsLeavesSolvent extraction—Phytochemical screeningResolve DOI
TanninsLeavesSolvent extraction—Phytochemical screeningResolve DOI
Gallic acidLive plantsSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
MimosineLive plantsSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
P-coumaric acidLive plantsSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
TanninsRoots and other underground partsSolvent extraction—Chromatographic testsNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverUnspecifiedSolvent extractionRat (as animal)Acute toxicityNo resolvable identifier
ReproductiveUrogenitalSeedSolvent extractionRat (as animal)Chronic/long term toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hullatti, Kirankumar., Pathade, Namrata., Mandavkar, Yuvaraj., Godavarthi, Ashok., Biradi, Mahesh. Bioactivity-guided isolation of cytotoxic constituents from three medicinal plants. PHARMACEUTICAL BIOLOGY, 2013, vol. 51, no. 5, p. 601-606. DOI
  2. Patel, Neeraj K., Bhutani, Kamlesh K. SUPPRESSIVE EFFECTS OF MIMOSA PUDICA (L.) CONSTITUENTS ON THE PRODUCTION OF LPS-INDUCED PRO-INFLAMMATORY MEDIATORS . Excli journal, 2014, vol. 13, p. 1011-1021.
  3. Sia, F. Y., Vejayan, J., Jamuna, A., Ambu, S. Efficacy of tannins from Mimosa pudica and tannic acid in neutralizing cobra (Naja kaouthia) venom. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2011, vol. 17, no. 1, p. 42-48.
  4. Nghonjuyi NW., Tiambo CK., Taiwe GS., Toukala JP., Lisita F., Juliano RS., Kimbi HK. Acute and sub-chronic toxicity studies of three plants used in Cameroonianethnoveterinary medicine: Aloe vera (L.) Burm. f. (Xanthorrhoeaceae) leaves,Carica papaya L. (Caricaceae) seeds or leaves, and Mimosa pudica L. (Fabaceae)leaves in Kabir chicks.. Journal of ethnopharmacology, 2016, vol. 178, p. 40-9. DOI
  5. G�mez Trujillo, Niurka Esther., Corella Del Toro, Isell., Cuti� Anido, Yudelkis., Rodr�guez Gra�a, Tania., Salinas Ojeda, Leticia. Hepatotoxicidad aguda de la decocci�n de la planta Mimosa p�dica en ratas Sprague Dawley . Correo cient�fico m�dico, 2014, vol. 18, no. 1, p. 25-32.
  6. Pokharkar, R.D., Saraswat, R.K., Kanawade, M.G. Contraceptive evaluation of oil extract of seeds of Mimosa pudica (L) in male wistar rats. Pharmacologyonline, 2009, vol. 3, p. 479-488.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.